Multimorbidity assessment, prioritisation, and management of care for people with commonly occurring multimorbidity : clinical assessment and management
Polypharmacy in people with multimorbidity is often driven by the introduction of multiple drugs intended to prevent future morbidity and mortality, but the case for using such drugs weakens as life expectancy reduces. The absolute difference made by each additional drug may also reduce when people...
| Corporate Authors: | , |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
London
National Institute for Health and Care Excellence
2016, September 2016
|
| Series: | NICE guideline: methods, evidence and recommendations
|
| Subjects: | |
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Table of Contents:
- Includes bibliographical references